Drug Innovation

Blog

Learn How Drug Price Controls Hurt Patients

Big Pharma Is Not Gouging Americans nor Driving Up Healthcare Costs

Whether it is Sanders vilifying pharmaceutical companies or Trump’s emphasis on imposing price controls, they both allege that drug spending is a primary driver of the nation’s rising healthcare costs. Even a cursory look at the data demonstrates their focus is misplaced. Let’s start with the national health expenditure data ...
Commentary

Drug Innovation is Dying in UK, Don’t Let it Happen Here

Drug companies are fleeing the United Kingdom. This month, Merck announced that it would cancel a proposed $1.3 billion research center in London and terminate all of its research and development efforts in the country. To justify its decision, the drugmaker cited “the overall undervaluation of innovative medicines and vaccines ...
Commentary

Kennedy’s Vaccine Policies Put Americans at Risk in More Ways Than One

The effects of Kennedy’s vaccines policies are going to hurt Americans – and not just because more people are falling ill. Health experts, former CDC directors, and medical associations are gravely concerned that HHS Secretary RFK Jr.’s actions are risking Americans’ health and wellbeing. Nine former directors of the CDC ...
Commentary

Cashing In On University Patents Means Giving Up On Our Innovation Future

Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation ...
Commentary

How innovation saves lives: What America’s pharmaceutical ecosystem gets right

When a woman is diagnosed with breast cancer in the United States today, her chances of surviving are much greater than in decades past — thanks to U.S. innovation. The incidence of breast cancer has increased by more than 200% globally in the past 40 years. But the U.S. mortality ...
Blog

Pulling mRNA Research Funding Undermines Future Innovations

Pulling mRNA Research Funding Undermines Future Innovations by Wayne Winegarden | August 15, 2025 The U.S. is a global leader in the innovative pharmaceutical industry, in part, because the public and private sectors effectively fulfill their complimentary roles. The federal government funds basic research that expands our knowledge base; the ...
Blog

Read part 3 of a series on drug pricing

Regulations, Not Anticompetitive Actions, Are Obstructing Drug Competition

The flaws driving up costs across the broader health care landscape are also driving up the costs for innovative drugs. After all, pharmaceuticals are an integral component used in combination with the broader healthcare system. As a result, spending on medicines both influences and is influenced by the spending on ...
Drug Innovation

New PRI Brief Warns Trump Drug Price Control Policies Would Lead U.S. Down the Path to European-Style Socialism

SACRAMENTO – The Center for Medical Economics and Innovation at the Pacific Research Institute – a nonpartisan, California-based, free market think tank – today released a new issue brief warning that efforts by the Trump administration and some Republicans in Congress to embrace and expand the government price controls on ...
Blog

The U.S. Drug System Strikes a Reasonable Balance Between Incentivizing Innovation and Promoting Competition

The government explicitly grants innovators temporary market exclusivity to provide an opportunity for groundbreaking pharmaceutical companies to recover the costs of capital associated with developing novel treatments. This was one of the express purposes of past federal reform legislation, such as the Hatch-Waxman Act signed in 1984 and the Biologics ...
Commentary

Trump Must Shut Down Counterfeit Weight-Loss Drugs

Americans looking to lose weight are increasingly turning to the internet. And they’re being duped. Telehealth startups and fly-by-night pharmacies are peddling what look like cheap, convenient versions of blockbuster drugs like Ozempic and Wegovy. But many of these offerings are neither authentic nor safe. They’re “compounded” copies — knockoffs ...
Blog

Learn How Drug Price Controls Hurt Patients

Big Pharma Is Not Gouging Americans nor Driving Up Healthcare Costs

Whether it is Sanders vilifying pharmaceutical companies or Trump’s emphasis on imposing price controls, they both allege that drug spending is a primary driver of the nation’s rising healthcare costs. Even a cursory look at the data demonstrates their focus is misplaced. Let’s start with the national health expenditure data ...
Commentary

Drug Innovation is Dying in UK, Don’t Let it Happen Here

Drug companies are fleeing the United Kingdom. This month, Merck announced that it would cancel a proposed $1.3 billion research center in London and terminate all of its research and development efforts in the country. To justify its decision, the drugmaker cited “the overall undervaluation of innovative medicines and vaccines ...
Commentary

Kennedy’s Vaccine Policies Put Americans at Risk in More Ways Than One

The effects of Kennedy’s vaccines policies are going to hurt Americans – and not just because more people are falling ill. Health experts, former CDC directors, and medical associations are gravely concerned that HHS Secretary RFK Jr.’s actions are risking Americans’ health and wellbeing. Nine former directors of the CDC ...
Commentary

Cashing In On University Patents Means Giving Up On Our Innovation Future

Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation ...
Commentary

How innovation saves lives: What America’s pharmaceutical ecosystem gets right

When a woman is diagnosed with breast cancer in the United States today, her chances of surviving are much greater than in decades past — thanks to U.S. innovation. The incidence of breast cancer has increased by more than 200% globally in the past 40 years. But the U.S. mortality ...
Blog

Pulling mRNA Research Funding Undermines Future Innovations

Pulling mRNA Research Funding Undermines Future Innovations by Wayne Winegarden | August 15, 2025 The U.S. is a global leader in the innovative pharmaceutical industry, in part, because the public and private sectors effectively fulfill their complimentary roles. The federal government funds basic research that expands our knowledge base; the ...
Blog

Read part 3 of a series on drug pricing

Regulations, Not Anticompetitive Actions, Are Obstructing Drug Competition

The flaws driving up costs across the broader health care landscape are also driving up the costs for innovative drugs. After all, pharmaceuticals are an integral component used in combination with the broader healthcare system. As a result, spending on medicines both influences and is influenced by the spending on ...
Drug Innovation

New PRI Brief Warns Trump Drug Price Control Policies Would Lead U.S. Down the Path to European-Style Socialism

SACRAMENTO – The Center for Medical Economics and Innovation at the Pacific Research Institute – a nonpartisan, California-based, free market think tank – today released a new issue brief warning that efforts by the Trump administration and some Republicans in Congress to embrace and expand the government price controls on ...
Blog

The U.S. Drug System Strikes a Reasonable Balance Between Incentivizing Innovation and Promoting Competition

The government explicitly grants innovators temporary market exclusivity to provide an opportunity for groundbreaking pharmaceutical companies to recover the costs of capital associated with developing novel treatments. This was one of the express purposes of past federal reform legislation, such as the Hatch-Waxman Act signed in 1984 and the Biologics ...
Commentary

Trump Must Shut Down Counterfeit Weight-Loss Drugs

Americans looking to lose weight are increasingly turning to the internet. And they’re being duped. Telehealth startups and fly-by-night pharmacies are peddling what look like cheap, convenient versions of blockbuster drugs like Ozempic and Wegovy. But many of these offerings are neither authentic nor safe. They’re “compounded” copies — knockoffs ...
Scroll to Top